A series of new non-fullerene small molecule acceptors ( NTIC , NTIC-Me , NTIC-OMe and NTIC-F ) based on the acceptor–donor–acceptor (A–D–A) architecture, using hexacyclic naphthalene-(cyclopentadithiophene) as the central unit, were designed and synthesized.
No takes yet. Share an insight, caveat, or question.
Yi et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: